摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(1H-benzoimidazol-2-yl)-1,1-diphenyl-urea | 24363-84-6

中文名称
——
中文别名
——
英文名称
3-(1H-benzoimidazol-2-yl)-1,1-diphenyl-urea
英文别名
3-(1H-benzimidazol-2-yl)-1,1-diphenylurea
3-(1<i>H</i>-benzoimidazol-2-yl)-1,1-diphenyl-urea化学式
CAS
24363-84-6
化学式
C20H16N4O
mdl
——
分子量
328.373
InChiKey
LDFZGSMBBFZISK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • SYMMETRICAL 2-AMINOPHENYL-BENZAZOLYL-5-ACETATE COMPOUNDS AND THEIR USE AS ANTI-HEPARANASE
    申请人:Leadiant Biosciences SA
    公开号:EP3381907A1
    公开(公告)日:2018-10-03
    The present invention relates to symmetrical 2-aminophenyl-benzazolyl-5-acetate compounds of formula (I). Such compounds are endowed with an anti-heparanase activity. The present invention also relates to the use of such compounds as a medicament, in particular for the treatment of diseases and disorders associated with a heparanase activity, and to pharmaceutical compositions comprising the same.
    本发明涉及符合式(I)的对称2-基苯基-苯并咪唑-5-乙酸酯化合物。这些化合物具有抗肝素酶活性。本发明还涉及将这些化合物用作药物,特别是用于治疗与肝素酶活性相关的疾病和紊乱,并涉及包含这些化合物的药物组合物。
  • [EN] (BENZIMIDAZOL-2-YL)-PHENYL-PHENYL-UREA COMPOUNDS AND METHODS FOR INHIBITING HEPARANASE ACTIVITY<br/>[FR] COMPOSES DE (BENZIMIDAZOL-2-YL)-PHENYL-PHENYL-UREE ET PROCEDES D'INHIBITION DE L'ACTIVITE DE L'HEPARANASE
    申请人:IMCLONE SYSTEMS INC
    公开号:WO2005042495A1
    公开(公告)日:2005-05-12
    The present invention encompasses heparanase inhibitors, particularly to certain (benzimidazol-2-yl)-phenyl-phenyl-urea derivatives that inhibit heparanase, pharmaceutical compositions that contain the compounds, methods for making the compounds, and methods of treating heparanase-dependent diseases and conditions in mammals by administering a therapeutically effective amount of the compounds to the mammals.
    本发明涉及抑制肝素酶的抑制剂,特别是某些(苯并咪唑-2-基)-苯基-苯基-生物,这些衍生物可以抑制肝素酶,以及包含这些化合物的制药组合物,制备这些化合物的方法,以及通过向哺乳动物施用治疗有效量的这些化合物来治疗肝素酶依赖性疾病和病况的方法。
  • [EN] SYMMETRICAL 2-AMINOPHENYL-BENZAZOLYL-5-ACETATE COMPOUNDS AND THEIR USE AS ANTI-HEPARANASE<br/>[FR] COMPOSÉS SYMÉTRIQUES DE 2-AMINOPHÉNYL-BENZAZOLYL-5-ACÉTATE ET LEUR UTILISATION COMME ANTI-HÉPARANASE
    申请人:LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE
    公开号:WO2018177857A1
    公开(公告)日:2018-10-04
    The present invention relates to symmetrical 2-aminophenyl-benzazolyl-5-acetate compoundsof formula (I). Such compounds are endowed with an anti-heparanase activity. The present invention also relates to the use of such compounds as a medicament, in particular for the treatment of diseases and disorders associated with a heparanase activity, and to pharmaceutical compositions comprising the same.
查看更多